France · Delayed Price · Currency is EUR OSE Immunotherapeutics Statistics
Total Valuation
EPA:OSE has a market cap or net worth of EUR 79.83 million. The enterprise value is 93.47 million.
| Market Cap | 79.83M |
| Enterprise Value | 93.47M |
Important Dates
The next confirmed earnings date is Monday, September 28, 2026.
| Earnings Date | Sep 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EPA:OSE has 23.52 million shares outstanding. The number of shares has increased by 5.12% in one year.
| Current Share Class | 23.52M |
| Shares Outstanding | 23.52M |
| Shares Change (YoY) | +5.12% |
| Shares Change (QoQ) | +3.65% |
| Owned by Insiders (%) | 23.01% |
| Owned by Institutions (%) | 2.90% |
| Float | 17.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.66 |
| PB Ratio | 2.88 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.31.
| Current Ratio | 1.28 |
| Quick Ratio | 1.17 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.06 |
| Interest Coverage | -13.29 |
Financial Efficiency
Return on equity (ROE) is -82.32% and return on invested capital (ROIC) is -81.29%.
| Return on Equity (ROE) | -82.32% |
| Return on Assets (ROA) | -23.10% |
| Return on Invested Capital (ROIC) | -81.29% |
| Return on Capital Employed (ROCE) | -69.47% |
| Weighted Average Cost of Capital (WACC) | 7.95% |
| Revenue Per Employee | 42,047 |
| Profits Per Employee | -588,891 |
| Employee Count | 64 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, EPA:OSE has paid 275,000 in taxes.
| Income Tax | 275,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.38% in the last 52 weeks. The beta is 0.82, so EPA:OSE's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -31.38% |
| 50-Day Moving Average | 4.00 |
| 200-Day Moving Average | 4.76 |
| Relative Strength Index (RSI) | 39.06 |
| Average Volume (20 Days) | 212,346 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:OSE had revenue of EUR 2.69 million and -37.69 million in losses. Loss per share was -1.69.
| Revenue | 2.69M |
| Gross Profit | 2.39M |
| Operating Income | -37.49M |
| Pretax Income | -37.41M |
| Net Income | -37.69M |
| EBITDA | -37.33M |
| EBIT | -37.49M |
| Loss Per Share | -1.69 |
Balance Sheet
The company has 22.65 million in cash and 36.29 million in debt, with a net cash position of -13.65 million or -0.58 per share.
| Cash & Cash Equivalents | 22.65M |
| Total Debt | 36.29M |
| Net Cash | -13.65M |
| Net Cash Per Share | -0.58 |
| Equity (Book Value) | 27.76M |
| Book Value Per Share | 1.24 |
| Working Capital | 7.09M |
Cash Flow
In the last 12 months, operating cash flow was -34.03 million and capital expenditures -98,000, giving a free cash flow of -34.13 million.
| Operating Cash Flow | -34.03M |
| Capital Expenditures | -98,000 |
| Depreciation & Amortization | 152,000 |
| Net Borrowing | -7.14M |
| Free Cash Flow | -34.13M |
| FCF Per Share | -1.45 |
Margins
| Gross Margin | 88.70% |
| Operating Margin | -1,392.98% |
| Pretax Margin | -1,390.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EPA:OSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.12% |
| Shareholder Yield | -5.12% |
| Earnings Yield | -47.21% |
| FCF Yield | -42.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for EPA:OSE is 14.07, which is 314.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 14.07 |
| Price Target Difference | 314.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 248.25% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:OSE has an Altman Z-Score of -0.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.53 |
| Piotroski F-Score | 2 |